Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels

Changfei Li; Mengmeng Deng; Jun Hu; Xin Li; Lizhao Chen; Ying Ju; Junli Hao; Songdong Meng

doi:10.18632/oncotarget.7740

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels

Changfei Li, Mengmeng Deng, Jun Hu, Xin Li, Lizhao Chen, Ying Ju, Junli Hao and Songdong Meng _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:17021-17034. https://doi.org/10.18632/oncotarget.7740

Metrics: PDF 1818 views | HTML 5785 views | ?

Abstract

Changfei Li1, Mengmeng Deng1, Jun Hu1, Xin Li1, Lizhao Chen1, Ying Ju1, Junli Hao2, Songdong Meng1

1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China

2School of Biomedical Sciences, Chengdu Medical college, Chengdu, China

Correspondence to:

Songdong Meng, e-mail: [email protected]

Junli Hao, e-mail: [email protected]

Keywords: C/EBPα, miR-122, IL-6, c-myc, TNF-α

Received: October 19, 2015 Accepted: February 05, 2016 Published: February 26, 2016

ABSTRACT

Persistent inflammation in chronic hepatitis plays a major role in the development of hepatocellular carcinoma (HCC). In this study, the major inflammatory cytokines expressed in chronic hepatitis, IL-6 and TNF-α, induced a marked decrease in microRNA-122 (miR-122) levels, and miR-122 expression was downregulated in the livers of chronic hepatitis B (CHB) patients. The decrease of miR-122 caused upregulation of the proinflammatory chemokine CCL2. IL-6 and TNF-α suppressed miR-122 both by directly downregulating the transcription factor C/EBPα and indirectly upregulating c-myc, which blocks C/EBPα-mediated miR-122 transcription. In addition, IL-6 and TNF-α levels were elevated and miR-122 levels were decreased in mouse and rat models of diethylnitrosamine (DEN)-induced HCC. Restoration of miR-122 levels through delivery of agomir-122 suppressed DEN-induced hepatocarcinogenesis in mice. Our results show that inflammation-induced miR-122 downregulation in hepatitis contributes to carcinogenesis and suggest that increasing miR-122 may be an effective strategy for preventing HCC development in CHB patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7740

Publication Alerts

Research Papers:

Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels

Abstract